As more states legalize cannabis, increasingly stringent testing requirements are being developed on the state level for pesticide and mycotoxin levels in cannabis products.
Regulations and Regulatory Issues
George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.
The complex question of whether or not data or results are valid involves both the testing process and the actual calculated results.
I Can’t Afford Good Science: The Battle Between Economics and Method Development in the Emerging Cannabis Market
One winter afternoon, a group of professionals and scientists came together to discuss the development of test methods for cannabis.
Using Method Detection Limits to Set Mandatory Reporting Limits for Banned Pesticides: How a Public-Private Partnership Improved Cannabis Regulation in Colorado
The regulation of pesticide use on cannabis is a complex issue for states with legalized marijuana.
The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.
When I want to hear some humorous stories, there are few friends in the instrument manufacturing and sales business I can contact.
On Nov. 1, 2017, FDA announced that it issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these statements.
In an interesting move, FDA sent out eight warning letters on Feb. 4, 2016 to various makers of a dietary supplement called cannabidiol, which is derived from the Cannabis plant.